Mike Matson

Q: What is Mike Matson's success rate?

Mike Matson currently has a success rate of 88.6361241250867.

Q: What is the average return of Mike Matson's calls?

Their stock ratings have generated an average return of 13.102768914139435.

Needham | Healthcare

Mike Matson is an analyst from Needham specializing in the Healthcare sector. Ranked #1947 out of 4535 analysts, they have issued 93 stock ratings with a success rate of 88.64% and an average return of 13.10%.

Mike Matson has a well-established track record, with 93 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 88.64% and an average return of 13.10%, underscoring their expertise and ability to identify winning opportunities for investors.

#1947

Out of 4535

Total Ratings

+88.64%

Success Rate

+13.10%

Average Return

Recent Ratings Analysis

MDT

Buy

Feb 09, 2026

Target

$121.00

Current

$101.65

Performance

0.00%

Mike Matson rated MDT as Buy on Feb 09, 2026, setting a price target of 121. Shares have remained stable near 101.65, leaving the 121 target still in play.

BSX

Buy

Feb 05, 2026

Target

$97.00

Current

$74.12

Performance

-4.53%

On Feb 05, 2026, BSX was given a Buy rating by Mike Matson, with a target price of 97. The stock traded sideways with a -4.53% move, keeping the bullish thesis unresolved.

AORT

Buy

Feb 02, 2026

Target

$58.00

Current

$39.61

Performance

-3.93%

AORT received a Buy rating from Mike Matson on Feb 02, 2026, aiming for 58. Price action was muted, as shares hovered around 39.61 despite the bullish outlook.

SYK

Buy

Jan 30, 2026

Target

$454.00

Current

$356.08

Performance

-3.65%

On Jan 30, 2026, Mike Matson published a Buy outlook on SYK, with a target of 454. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 356.08.

CNMD

Hold

Jan 29, 2026

Target

$0.00

Current

$41.67

Performance

11.69%

Mike Matson on Jan 29, 2026 assigned CNMD a Hold rating, with a price target of null. Shares outperformed expectations, climbing 11.69% despite the neutral view.

TFX

Buy

Jan 27, 2026

Target

$138.00

Current

$106.21

Performance

1.62%

On Jan 27, 2026, Mike Matson reaffirmed TFX with a Buy rating, targeting 138. Market indecision has kept the 138 target in a holding pattern.

PEN

Hold

Jan 16, 2026

Target

$0.00

Current

$339.05

Performance

-3.34%

PEN was rated Hold by Mike Matson on Jan 16, 2026, with a price objective of null. Flat performance suggests the Hold view was reasonable.

ESTA

Buy

Jan 12, 2026

Target

$84.00

Current

$69.51

Performance

4.12%

On Jan 12, 2026, Mike Matson initiated coverage on ESTA with a Buy rating and target of 84. Neutral price movement of 4.12% leaves room for interpretation.

NEO

Buy

Jan 12, 2026

Target

$14.00

Current

$11.35

Performance

-9.13%

Mike Matson issued a Buy recommendation for NEO on Jan 12, 2026, price target set at 14. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

MMSI

Buy

Jan 09, 2026

Target

$108.00

Current

$80.83

Performance

-6.43%

On Jan 09, 2026, MMSI was evaluated by Mike Matson, who gave a Buy rating and target of 108. Investors saw limited payoff as shares fell short of the 108 target.

HAE

Hold

Dec 15, 2025

Target

$0.00

Current

$57.69

Performance

-28.25%

Mike Matson rated HAE as Hold on Dec 15, 2025, setting a price target of null. The cautious Hold call aligned with subsequent weakness, as shares slipped 28.25%.

TMDX

Buy

Dec 08, 2025

Target

$166.00

Current

$136.34

Performance

-0.19%

On Dec 08, 2025, TMDX was given a Buy rating by Mike Matson, with a target price of 166. The stock traded sideways with a -0.19% move, keeping the bullish thesis unresolved.

LUCD

Buy

Nov 13, 2025

Target

$3.00

Current

$1.23

Performance

14.95%

LUCD received a Buy rating from Mike Matson on Nov 13, 2025, aiming for 3. Momentum has favored the Buy call, with shares climbing from 1.23 to 1.23, rewarding those who trusted the recommendation.

IMDX

Buy

Nov 11, 2025

Target

$9.00

Current

$7.14

Performance

-5.18%

On Nov 11, 2025, Mike Matson published a Buy outlook on IMDX, with a target of 9. Market action contradicted the Buy thesis, as shares slipped to 7.14.

VCYT

Buy

Nov 05, 2025

Target

$44.00

Current

$36.73

Performance

-20.22%

Mike Matson on Nov 05, 2025 assigned VCYT a Buy rating, with a price target of 44. The call has struggled to gain traction, with shares losing 20.22%.

PSNL

Buy

Nov 05, 2025

Target

$10.00

Current

$7.83

Performance

2.22%

On Nov 05, 2025, Mike Matson reaffirmed PSNL with a Buy rating, targeting 10. Market indecision has kept the 10 target in a holding pattern.

KIDS

Buy

Oct 29, 2025

Target

$26.00

Current

$16.71

Performance

1.52%

KIDS was rated Buy by Mike Matson on Oct 29, 2025, with a price objective of 26. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

HOLX

Hold

Oct 21, 2025

Target

$0.00

Current

$75.02

Performance

1.41%

On Oct 21, 2025, Mike Matson initiated coverage on HOLX with a Hold rating and target of null. The stock’s lack of movement around 75.02 aligned with a cautious approach.

INMD

Hold

Oct 10, 2025

Target

$0.00

Current

$15.12

Performance

-0.98%

Mike Matson issued a Hold recommendation for INMD on Oct 10, 2025, price target set at null. The rating was appropriate for a consolidating market trading near 15.12.

LIVN

Buy

Sep 03, 2025

Target

$64.00

Current

$65.74

Performance

16.17%

On Sep 03, 2025, LIVN was evaluated by Mike Matson, who gave a Buy rating and target of 64. This case illustrates how a timely bullish rating can translate into tangible gains of 16.17%.

ENOV

Buy

Aug 07, 2025

Target

$49.00

Current

$22.36

Performance

-21.60%

Mike Matson rated ENOV as Buy on Aug 07, 2025, setting a price target of 49. The stock has underperformed, dropping 21.60% despite the bullish target of 49.

ATRC

Buy

Jul 30, 2025

Target

$45.00

Current

$36.92

Performance

5.10%

On Jul 30, 2025, ATRC was given a Buy rating by Mike Matson, with a target price of 45. The stock rallied 5.10% after the rating, narrowing the gap to the target of 45 and validating the bullish stance.

MASI

Hold

Apr 10, 2025

Target

$0.00

Current

$134.80

Performance

-11.02%

MASI received a Hold rating from Mike Matson on Apr 10, 2025, aiming for null. The Hold stance proved prudent, with the market softening by 11.02%.

INGN

Hold

Apr 09, 2025

Target

$0.00

Current

$5.59

Performance

-20.60%

On Apr 09, 2025, Mike Matson published a Hold outlook on INGN, with a target of null. Weakness in the stock, now at 5.59, supported the conservative rating.

OCX

Buy

Apr 08, 2025

Target

$4.25

Current

$3.20

Performance

16.36%

Mike Matson on Apr 08, 2025 assigned OCX a Buy rating, with a price target of 4.25. The Buy call aligned well with market performance, producing a gain of 16.36%.

ICUI

Hold

Apr 08, 2025

Target

$0.00

Current

$151.86

Performance

13.35%

On Apr 08, 2025, Mike Matson reaffirmed ICUI with a Hold rating, targeting null. Market strength beyond 151.86 went further than the conservative outlook suggested.

STE

Hold

Apr 07, 2025

Target

$0.00

Current

$245.40

Performance

15.34%

STE was rated Hold by Mike Matson on Apr 07, 2025, with a price objective of null. Despite caution, upside momentum rewarded risk-takers with gains to 245.4.

ZBH

Hold

Feb 07, 2025

Target

$0.00

Current

$89.73

Performance

-11.10%

On Feb 07, 2025, Mike Matson initiated coverage on ZBH with a Hold rating and target of null. The rating matched the stock’s inability to hold above 89.73.

RMD

Hold

Jan 31, 2025

Target

$0.00

Current

$275.96

Performance

16.84%

Mike Matson issued a Hold recommendation for RMD on Jan 31, 2025, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

SRDX

Hold

Jan 30, 2025

Target

$0.00

Current

$42.98

Performance

21.14%

On Jan 30, 2025, SRDX was evaluated by Mike Matson, who gave a Hold rating and target of null. Investors who stayed in despite the Hold saw upside of 21.14%.

FNA

Hold

Jan 29, 2025

Target

$13.00

Current

$13.09

Performance

0.77%

Mike Matson rated FNA as Hold on Jan 29, 2025, setting a price target of 13. The Hold stance appears justified, as shares hovered around 13.09 with a 0.77% move.

NARI

Hold

Oct 09, 2024

Target

$0.00

Current

$79.97

Performance

91.82%

On Oct 09, 2024, NARI was given a Hold rating by Mike Matson, with a target price of null. The stock rallied from 79.97 to 79.97 after the Hold rating, surprising to the upside.

AXNX

Hold

May 06, 2024

Target

$0.00

Current

$70.98

Performance

5.02%

AXNX received a Hold rating from Mike Matson on May 06, 2024, aiming for null. Investors saw gains of 5.02% that the cautious stance didn’t fully capture.

Frequency Asked Questions

Who is Mike Matson?

Mike Matson is an analyst from Needham specializing in the Healthcare sector.

What is Mike Matson's success rate?

Mike Matson currently has a success rate of +88.64%.

How many ratings has Mike Matson issued?

Mike Matson has issued 93 stock ratings so far.

What is the average return of Mike Matson's calls?

Their stock ratings have generated an average return of +13.10%.

What is Mike Matson's ranking?

Mike Matson is ranked #1947 out of 4535 analysts.

What types of ratings does Mike Matson give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Mike Matson?

You can follow Mike Matson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Mike Matson?

Their latest rating was a Buy on MDT issued on 2026-02-09.